Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05096221 |
|---|---|
| Brief Title: | A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD) (EMBARK) |
| First Submitted : | October 14, 2021 |
| First Submitted that Met QC Criteria : | October 14, 2021 |
| First Posted : | October 27, 2021 |
| Last Update Submitted that Met QC Criteria : | November 3, 2023 |
| Last Update Posted : | November 7, 2023 |